share_log

花旗:维持Larimar Therapeutics(LRMR.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至14.00美元。

Zhitong Finance ·  May 22 13:54

花旗:维持Larimar Therapeutics(LRMR.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至14.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment